Boron neutron capture therapy: moving towards targeted therapy for locally recurrent head and neck squamous cell carcinoma
Abstract Locally recurrent head and neck squamous cell carcinoma (HNSCC) is often unresectable, and a repeat course of radiotherapy is associated with incremental toxicities. Boron neutron capture therapy (BNCT) is a novel targeted radiotherapy modality that can achieve a high dose gradient between...
Main Author: | Ying Sun |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2019-10-01
|
Series: | Military Medical Research |
Subjects: | |
Online Access: | http://link.springer.com/article/10.1186/s40779-019-0224-7 |
Similar Items
-
Current status of boron neutron capture therapy of high grade gliomas and recurrent head and neck cancer
by: Barth Rolf F, et al.
Published: (2012-08-01) -
Prevention and early management of carotid blowout syndrome for patients receiving head and neck salvage boron neutron capture therapy (BNCT)
by: Tien-Li Lan, et al.
Published: (2021-07-01) -
Clinical trials for treating recurrent head and neck cancer with boron neutron capture therapy using the Tsing-Hua Open Pool Reactor
by: Ling-Wei Wang, et al.
Published: (2018-06-01) -
Dynamic changes in 18F-borono-L-phenylalanine uptake in unresectable, advanced, or recurrent squamous cell carcinoma of the head and neck and malignant melanoma during boron neutron capture therapy patient selection
by: Takahiro Morita, et al.
Published: (2018-01-01) -
Boron delivery agents for neutron capture therapy of cancer
by: Rolf F. Barth, et al.
Published: (2018-06-01)